253 related articles for article (PubMed ID: 12542901)
1. Continuous infusion versus intermittent administration of cefepime in patients with Gram-negative bacilli bacteraemia.
Jaruratanasirikul S; Sriwiriyajan S; Ingviya N
J Pharm Pharmacol; 2002 Dec; 54(12):1693-6. PubMed ID: 12542901
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactam using Monte Carlo simulations and steady-state pharmacokinetic data from hospitalized patients.
Shea KM; Cheatham SC; Smith DW; Wack MF; Sowinski KM; Kays MB
Ann Pharmacother; 2009 Nov; 43(11):1747-54. PubMed ID: 19809009
[TBL] [Abstract][Full Text] [Related]
4. Steady-state pharmacokinetics and pharmacodynamics of cefepime administered by prolonged infusion in hospitalised patients.
Cheatham SC; Shea KM; Healy DP; Humphrey ML; Fleming MR; Wack MF; Smith DW; Sowinski KM; Kays MB
Int J Antimicrob Agents; 2011 Jan; 37(1):46-50. PubMed ID: 21074370
[TBL] [Abstract][Full Text] [Related]
5. Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia.
Boselli E; Breilh D; Duflo F; Saux MC; Debon R; Chassard D; Allaouchiche B
Crit Care Med; 2003 Aug; 31(8):2102-6. PubMed ID: 12973166
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusion.
Burgess DS; Hastings RW; Hardin TC
Clin Ther; 2000 Jan; 22(1):66-75. PubMed ID: 10688391
[TBL] [Abstract][Full Text] [Related]
7. Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen.
Georges B; Conil JM; Cougot P; Decun JF; Archambaud M; Seguin T; Chabanon G; Virenque C; Houin G; Saivin S
Int J Clin Pharmacol Ther; 2005 Aug; 43(8):360-9. PubMed ID: 16119511
[TBL] [Abstract][Full Text] [Related]
8. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A
Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML
Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of pharmacokinetics/ pharmacodynamics of ciprofloxacin between 400 mg intravenously every 8 h and 400 mg intravenously every 12 h in patients with gram negative bacilli bacteremia.
Saengsuwan P; Jaruratanasirikul S; Jullangkoon M; Aeinlang N
J Med Assoc Thai; 2010 Jul; 93(7):784-8. PubMed ID: 20649056
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients.
Rafati MR; Rouini MR; Mojtahedzadeh M; Najafi A; Tavakoli H; Gholami K; Fazeli MR
Int J Antimicrob Agents; 2006 Aug; 28(2):122-7. PubMed ID: 16815689
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.
Burgess DS; Summers KK; Hardin TC
Clin Ther; 1999 Nov; 21(11):1882-9. PubMed ID: 10890260
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the pharmacodynamics of meropenem in healthy volunteers following administration by intermittent infusion or bolus injection.
Jaruratanasirikul S; Sriwiriyajan S
J Antimicrob Chemother; 2003 Sep; 52(3):518-21. PubMed ID: 12917242
[TBL] [Abstract][Full Text] [Related]
14. Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli.
Lorente L; Lorenzo L; Martín MM; Jiménez A; Mora ML
Ann Pharmacother; 2006 Feb; 40(2):219-23. PubMed ID: 16449546
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic profiling of cefepime in plasma and cerebrospinal fluid of hospitalized patients with external ventriculostomies.
Lodise TP; Rhoney DH; Tam VH; McKinnon PS; Drusano GL
Diagn Microbiol Infect Dis; 2006 Mar; 54(3):223-30. PubMed ID: 16423490
[TBL] [Abstract][Full Text] [Related]
16. Ocular penetration of cefepime following systemic administration in humans.
Ozdamar A; Aras C; Ozturk R; Karacorlu M; Bahcecioglu H; Ozkan S
Ophthalmic Surg Lasers; 2001; 32(1):25-9. PubMed ID: 11195739
[TBL] [Abstract][Full Text] [Related]
17. Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
Pharmacotherapy; 1998; 18(5):1069-74. PubMed ID: 9758317
[TBL] [Abstract][Full Text] [Related]
18. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients.
Malone RS; Fish DN; Abraham E; Teitelbaum I
Antimicrob Agents Chemother; 2001 Nov; 45(11):3148-55. PubMed ID: 11600370
[TBL] [Abstract][Full Text] [Related]
20. Perioperative pharmacokinetics of cefotaxime in serum and bile during continuous and intermittent infusion in liver transplant patients.
Buijk SE; Gyssens IC; Mouton JW; Metselaar HJ; Groenland TH; Verbrugh HA; Bruining HA
J Antimicrob Chemother; 2004 Jul; 54(1):199-205. PubMed ID: 15175266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
